Edwards Lifesciences Corporation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Edwards Lifesciences Corporation (EW) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $16.00 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2026-08-04
- 2026-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $16.00M.
- 2026-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $16.00M.
- 2025-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $8.10M.
- 2025-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $8.10M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2026-06-30 | $16.00M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $16.00M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $8.10M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $8.10M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $22.60M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $22.60M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $21.50M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $8.80M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $5.00M 10-Q · filed 2025-08-06 |
| 2024-03-31 | $5.00M 10-Q · filed 2025-05-06 |
| 2023-12-31 | $10.30M 10-K · filed 2026-02-25 |
| 2023-06-30 | $14.00M 10-Q · filed 2023-07-28 |
| 2023-03-31 | $40.90M 10-Q · filed 2023-04-28 |
| 2022-12-31 | $40.20M 10-K · filed 2025-02-28 |
| 2022-09-30 | $39.70M 10-Q · filed 2022-10-28 |
| 2022-06-30 | $52.20M 10-Q · filed 2023-07-28 |
| 2022-03-31 | $73.10M 10-Q · filed 2023-04-28 |
| 2021-12-31 | $76.00M 10-Q · filed 2023-07-28 |
| 2021-09-30 | $94.10M 10-Q · filed 2022-10-28 |
| 2021-06-30 | $93.00M 10-Q · filed 2022-07-29 |
| 2021-03-31 | $181.60M 10-Q · filed 2022-04-28 |
| 2020-12-31 | $186.10M 10-K · filed 2023-02-13 |
| 2020-09-30 | $180.90M 10-Q · filed 2021-10-29 |
| 2020-06-30 | $189.90M 10-Q · filed 2021-07-30 |
| 2020-03-31 | $170.30M 10-Q · filed 2021-04-28 |
| 2019-12-31 | $172.50M 10-K · filed 2022-02-14 |
| 2019-09-30 | $191.00M 10-Q · filed 2020-10-26 |
| 2019-06-30 | $193.30M 10-Q · filed 2020-07-27 |
| 2019-03-31 | $185.30M 10-Q · filed 2020-04-28 |
| 2018-12-31 | $178.60M 10-K · filed 2021-02-12 |
| 2018-09-30 | $192.60M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $199.00M 10-Q · filed 2018-07-27 |
| 2018-03-31 | $238.10M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $244.30M 10-K · filed 2020-02-14 |
| 2017-09-30 | $182.00M 10-Q · filed 2017-10-27 |
| 2017-06-30 | $198.70M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $195.60M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $31.60M 10-K · filed 2018-02-16 |
| 2016-09-30 | $31.60M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $31.50M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $31.10M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $30.50M 10-K · filed 2017-02-17 |
| 2015-09-30 | $30.30M 10-Q · filed 2015-10-29 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |